about
Recent developments in adenosine receptor ligands and their potential as novel drugsAdenosine receptors and the kidneyAdenoprotection of the heart involves phospholipase C-induced activation and translocation of PKC-epsilon to RACK2 in adult rat and mouse.Adenosine kinase regulation of cardiomyocyte hypertrophy.Winning a Won Game: Caffeine Panacea for Obesity SyndemicAMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts.Cardiac purinergic signalling in health and diseaseAntagonist selective modulation of adenosine A1 and A3 receptor pharmacology by the food dye Brilliant Black BN: evidence for allosteric interactionsEvidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells.The structural basis of ATP as an allosteric modulatorConsecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioningEvidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptorIschemic conditioning: the challenge of protecting the diabetic heart.Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?Expression pattern of thymosin beta 4 in the adult human liver.Recent advances in the diagnosis and treatment of acute myocardial infarctionExtracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic PreconditioningEribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors.Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.Differential Tissue-Specific Function of Adora2b in Cardioprotection.Modulation of bladder function by luminal adenosine turnover and A1 receptor activation.Introduction to adenosine receptors as therapeutic targets.Upregulated autophagy protects cardiomyocytes from oxidative stress-induced toxicity.Involvement of adenosine and standardization of aqueous extract of garlic (Allium sativum Linn.) on cardioprotective and cardiodepressant properties in ischemic preconditioning and myocardial ischemia-reperfusion induced cardiac injuryA Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion.Cardioprotection requires taking out the trashEndocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue.Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog.Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue.Loss of cardioprotection with ageing.Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury.Efficacy and safety of ticagrelor: a reversible P2Y12 receptor antagonist.Phospholipase C as a potential target for cardioprotection during oxidative stress.Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches.Autophagy, myocardial protection, and the metabolic syndrome.Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy.Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning.Fractional flow reserve as a surrogate for inducible myocardial ischaemia.
P2860
Q27687253-A30DBB7C-2FA1-460F-8D78-067F73B32C78Q28253255-C890D46D-EFFE-4AD5-A523-AB2C904491AFQ29346989-7F3EF767-554C-4EAB-8F61-C7BFE6CAD633Q29347052-0FDA574D-666F-4DB6-A12A-B87656C663C4Q29540785-00BFF654-CF18-405A-BFDC-7246F9C2BC8DQ30433596-5ED81F23-86DD-482A-AF6F-CBF59890AA86Q33165093-7F1BCB25-8AD7-41D0-8047-7987A15A7886Q33754822-756D5D9E-6C61-4723-A920-EB39970A73D8Q33917045-1048DA41-B8E5-4F49-AA76-AED92F825DB1Q34127977-EEE99B30-3241-4D2E-886A-DE0624AB74C0Q34165655-701D0537-9D55-4C30-BAA7-7E5BA461A7FDQ34187821-96049705-024A-4F4D-B3B2-10D2B4B2FEE3Q34216786-76B36645-412E-4C58-8879-326076012CA6Q34457775-86F0D799-D89E-4C76-B1BD-1785A6E9F55EQ35286339-AFDFDD7B-CFC5-4019-A62D-38873A0698EAQ35467060-6A55FAEE-AC8F-489F-8D05-4B2A84A07C21Q35626702-05BC8E2F-2BA2-4464-8E8C-006606C0DAA8Q35742277-A2E3478F-F76E-44BD-BC71-285CE289E9A2Q35745405-2E0A4728-016F-40EF-9D7E-0903D87F7FE5Q35754166-12436455-7D75-4D6B-9AF0-A4488F8DB54EQ36078415-EE616A08-6F7F-4D74-8421-3D3498F73745Q36114999-CC843C2A-8A5D-400A-AA2C-48961C54C5C8Q36153376-F7F95408-484E-4B1E-8FBB-D31E3909A2B2Q36662346-49D1115C-DDB2-4218-8F2A-0C2F7FE9D1C4Q36680094-46D38AA8-CB4B-41A4-96A1-CBFAFE5750AEQ36852542-8F57C376-CDF1-4473-B333-99FE1222A905Q36867684-153E44B4-542F-460E-AE88-DF306B32FF2DQ37199307-BD006473-8F73-4AB5-9A21-7070E82D3905Q37264470-836450DE-72A0-4B3F-AFCC-C510601CB128Q37319985-3C51CA33-1D74-445D-AE1F-3CE1586AD5A2Q37379567-685335EA-B830-4EF6-89ED-45EA848F9B7FQ37407038-DDA9B947-7520-4D8A-AEDC-6357545EFFBAQ37685847-48340EB4-B526-4E63-A338-6C424056CB44Q37731344-A7CF6BB0-37EE-4E71-83A3-647C16D6D2C2Q37871976-288B252F-A902-45DF-86EC-E03AA4C83466Q37957791-E18FC8FB-E798-451D-B8C9-B4E12E8A6717Q37999635-3783118B-7D18-485D-93FC-68D562341EEEQ38010782-356713D6-EBDB-41F7-A66D-085287532B03Q38061499-C799EEC2-2B30-4842-8C5B-B90BB47EC5D8Q38113445-94346D80-63B2-48CF-A8BC-57D611A48105
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Adenosine: trigger and mediator of cardioprotection.
@ast
Adenosine: trigger and mediator of cardioprotection.
@en
Adenosine: trigger and mediator of cardioprotection.
@nl
type
label
Adenosine: trigger and mediator of cardioprotection.
@ast
Adenosine: trigger and mediator of cardioprotection.
@en
Adenosine: trigger and mediator of cardioprotection.
@nl
prefLabel
Adenosine: trigger and mediator of cardioprotection.
@ast
Adenosine: trigger and mediator of cardioprotection.
@en
Adenosine: trigger and mediator of cardioprotection.
@nl
P2860
P1476
Adenosine: trigger and mediator of cardioprotection.
@en
P2093
James M Downey
Michael V Cohen
P2860
P2888
P304
P356
10.1007/S00395-007-0687-7
P577
2007-11-12T00:00:00Z
P6179
1002750989